Confirming microarray data—is it really necessary?

Abstract The generation of corroborative data has become a commonly used approach for ensuring the veracity of microarray data. Indeed, the need to conduct corroborative studies has now become official editorial policy for at least 2 journals, and several more are considering introducing such a policy. The issue of corroborating microarray data is a challenging one—there are good arguments for and against conducting such experiments. However, we believe that the introduction of a fixed requirement to corroborate microarray data, especially if adopted by more journals, is overly burdensome and may, in at least several applications of microarray technology, be inappropriate. We also believe that, in cases in which corroborative studies are deemed essential, a lack of clear guidance leaves researchers unclear as to what constitutes an acceptable corroborative study. Guidelines have already been outlined regarding the details of conducting microarray experiments. We propose that all stakeholders, including journal editorial boards, reviewers, and researchers, should undertake concerted and inclusive efforts to address properly and clarify the specific issue of corroborative data. In this article we highlight some of the thorny and vague areas for discussion surrounding this issue. We also report the results of a poll in which 76 life science journals were asked about their current or intended policies on the inclusion of corroborative studies in papers containing microarray data.

[1]  Lee Bennett,et al.  Gene expression analysis reveals chemical-specific profiles. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  Stephen M. Hewitt,et al.  Post-analysis follow-up and validation of microarray experiments , 2002, Nature Genetics.

[3]  Syril D. Pettit,et al.  Use of Genomics in Mechanism Based Risk Assessment , 2003 .

[4]  H. Taubert,et al.  Alternative and aberrant splicing of MDM2 mRNA in human cancer. , 2002, Cancer cell.

[5]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.

[6]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[7]  Lucila Ohno-Machado,et al.  Analysis of matched mRNA measurements from two different microarray technologies , 2002, Bioinform..

[8]  D. Pisetsky,et al.  DNA microarrays: boundless technology or bound by technology? Guidelines for studies using microarray technology. , 2002, Arthritis and rheumatism.

[9]  Graham Cameron,et al.  One-stop shop for microarray data , 2000, Nature.

[10]  C Stratowa,et al.  CDNA microarray gene expression analysis of B‐cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking , 2001, International journal of cancer.

[11]  J. Hudson,et al.  Development of a prostate cDNA microarray and statistical gene expression analysis package , 2000, Molecular carcinogenesis.

[12]  T R Zacharewski,et al.  Assessment of clone identity and sequence fidelity for 1189 IMAGE cDNA clones. , 2001, Nucleic acids research.

[13]  M Waters,et al.  Systems Toxicology and the Chemical Effects in Biological Systems (CEBS) Knowledge Base , 2003, EHP toxicogenomics : journal of the National Institute of Environmental Health Sciences.

[14]  Christopher J. Lee,et al.  A genomic view of alternative splicing , 2002, Nature Genetics.

[15]  R. Dunn,et al.  Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  Neil Winegarden,et al.  Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA , 2002, Nature Biotechnology.

[17]  S. P. Fodor,et al.  Multiplexed biochemical assays with biological chips , 1993, Nature.

[18]  Gideon Rechavi,et al.  DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1 , 2001, Oncogene.

[19]  M. West,et al.  Gene expression predictors of breast cancer outcomes , 2003, The Lancet.

[20]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[21]  Jonathan Knight,et al.  When the chips are down , 2001, Nature.

[22]  D Cogdell,et al.  Sequence verification as quality-control step for production of cDNA microarrays. , 2001, BioTechniques.

[23]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[24]  Yusuke Nakamura,et al.  Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome‐wide cDNA Microarray Analysis , 2002, Japanese journal of cancer research : Gann.

[25]  To confirm or not to confirm (microarray data)--that is the question. , 2003, Drug discovery today.

[26]  F R Sharp,et al.  Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: Blood genomic fingerprints of disease , 2001, Annals of neurology.

[27]  Mark W. Craven,et al.  Identification of toxicologically predictive gene sets using cDNA microarrays. , 2001, Molecular pharmacology.

[28]  J Carl Barrett,et al.  Microarrays: the use of oligonucleotides and cDNA for the analysis of gene expression. , 2003, Drug discovery today.

[29]  Teruhiko Yoshida,et al.  A faithful method for PCR-mediated global mRNA amplification and its integration into microarray analysis on laser-captured cells. , 2003, Biochemical and biophysical research communications.

[30]  Hideaki Sugawara,et al.  DNA Data Bank of Japan (DDBJ) in XML , 2003, Nucleic Acids Res..